| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.86M | 62.86M | 64.47M | 54.06M | 49.04M | 47.52M |
| Gross Profit | 32.21M | 32.21M | 29.77M | 34.54M | 24.77M | 28.23M |
| EBITDA | -4.86M | -7.11M | -6.20M | 1.85M | -7.88M | -9.63M |
| Net Income | -8.68M | -8.68M | -8.44M | -2.36M | -12.05M | -10.85M |
Balance Sheet | ||||||
| Total Assets | 26.75M | 26.75M | 35.73M | 37.43M | 34.02M | 38.78M |
| Cash, Cash Equivalents and Short-Term Investments | 1.94M | 1.94M | 3.23M | 5.56M | 3.31M | 3.16M |
| Total Debt | 11.96M | 11.96M | 15.95M | 18.20M | 23.63M | 17.09M |
| Total Liabilities | 63.89M | 63.89M | 68.28M | 66.49M | 60.44M | 54.96M |
| Stockholders Equity | -37.13M | -37.13M | -32.55M | -29.05M | -26.42M | -16.18M |
Cash Flow | ||||||
| Free Cash Flow | -4.68M | -4.68M | 4.99M | 6.02M | -1.71M | -5.74M |
| Operating Cash Flow | -4.14M | -4.14M | 5.19M | 6.18M | -744.00K | -4.99M |
| Investing Cash Flow | -536.00K | -536.00K | -202.00K | -163.00K | -969.00K | -1.12M |
| Financing Cash Flow | 3.39M | 3.39M | -4.95M | -3.66M | 2.04M | 2.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $11.01M | ― | -335.48% | ― | -12.60% | 95.87% | |
| ― | $10.12M | -0.64 | -235.41% | ― | 0.36% | -17.20% | |
| ― | $8.01M | -1.82 | -69.61% | ― | -11.31% | 47.64% | |
| ― | $11.44M | 0.37 | ― | ― | -73.36% | ― | |
| ― | $5.67M | -0.46 | ― | ― | ― | ― | |
| ― | $8.08M | ― | -193.24% | ― | -66.40% | 65.99% |
On October 15, 2025, DIH Holdings US, Inc. entered into a purchase agreement with an investor to sell up to $22 million in Class A common stock or 10,458,031 shares, representing 19.99% of the company’s voting power. The company plans to use the proceeds for working capital and general purposes, with the agreement allowing the investor to purchase shares at a discounted price. The issuance is exempt from registration under the Securities Act, with a registration statement to be filed for resale. The agreement will terminate automatically after 36 months unless terminated earlier.
On October 17, 2025, DIH Holding US, Inc. implemented a one-for-twenty-five reverse stock split of its Class A common stock, following approval from its stockholders on September 25, 2025. The reverse stock split, effective at market open on October 20, 2025, aims to consolidate shares without affecting the total authorized shares or the par value, with stockholders receiving whole shares in place of fractional ones. This move is expected to streamline the company’s stock structure while maintaining stockholder ownership percentages and voting power.
DIH Holdings US, Inc. is facing potential delisting from the Nasdaq Stock Market due to non-compliance with several listing rules. The company has failed to meet the minimum market value of publicly held shares, market value of listed securities, and bid price requirements, as well as filing deadlines for financial reports. Despite requesting a hearing and an extension to address these deficiencies, there is no assurance that the Nasdaq Hearings Panel will grant the company’s request for continued listing or that it will achieve compliance within the allowed timeframe.
On March 11, 2025, DIH Holding US, Inc. received a notice from Nasdaq that its Class A common stock had closed below $1.00 for 30 consecutive business days, risking delisting under Nasdaq’s Bid Price Rule. By September 12, 2025, the company had not regained compliance and faced additional delisting risks due to delays in filing required financial reports. DIH requested a hearing to present a compliance plan and sought an extension to meet Nasdaq’s listing criteria, but there is no assurance of a favorable outcome.
On September 25, 2025, DIH Holding US, Inc. held a Special Meeting where several proposals were presented and approved by the shareholders. These proposals included the approval of potential issuance of more than 19.99% of the company’s common stock, reduction of the base conversion price of debentures, amendment to allow additional investments at a reduced price, and a reverse stock split. The approval of these proposals is expected to impact the company’s financial structure and market positioning, potentially enhancing its capital management and shareholder value.
On March 11, 2025, DIH Holding US, Inc. received a notice from Nasdaq regarding non-compliance with the bid price rule, as its stock price had been below $1.00 for 30 consecutive days. The company was given until September 8, 2025, to regain compliance, but failed to do so, leading to an additional delisting notice on September 12, 2025. Additionally, DIH was not in compliance with filing requirements and the minimum market value of listed securities rule. The company has requested a hearing to present its compliance plan and seek an extension, but there is no assurance that Nasdaq will grant the request.
On September 10, 2025, DIH Holding US, Inc. announced a change to its corporate governance structure by amending its By-Laws to reduce the quorum requirement from a majority to one-third of the shares outstanding. This adjustment could potentially streamline decision-making processes and impact shareholder influence in company meetings.
On September 2, 2025, DIH Holding US, Inc. appointed Dr. Barrett Mooney to its Board of Directors, effective until the 2026 Annual Meeting of Stockholders. Dr. Mooney brings a wealth of experience in growing complex and manufacturing-related businesses, having previously led AI-driven solutions in supply chain management and served as CEO of an aerospace and defense company. His appointment is expected to bolster DIH’s growth strategy in the rehabilitation robotics market. The board now consists of seven members, including five independent members, reinforcing the company’s commitment to strong governance.
On March 5, 2025, DIH Holding US, Inc. received a notice from Nasdaq indicating that its market value of listed securities had fallen below the required threshold for 30 consecutive days, leading to a compliance period until September 1, 2025, which the company failed to meet. Consequently, on September 2, 2025, Nasdaq notified DIH of its securities being subject to delisting unless a hearing is requested. The company plans to request a hearing to present its compliance plan and seek an extension, though there is no assurance of a favorable outcome.
On August 26, 2025, DIH Holding US, Inc. received a notice from Nasdaq for failing to timely file its Form 10-Q and Form 10-K with the SEC, putting it out of compliance with Nasdaq’s listing requirements. The company has until September 29, 2025, to submit a compliance plan and is working to file the reports to regain compliance. This notice does not immediately affect the company’s Nasdaq listing or trading.
DIH Holdings US, Inc Class A has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The primary reason for the delay is the need for additional time to finalize financial statements and disclosures, compounded by the fact that the company has not yet filed its Annual Report on Form 10-K (Yearly Report) for the fiscal year ended March 31, 2025. The company does not anticipate being able to file the Form 10-Q within the extension period provided by Rule 12b-25. Despite the delay, the company does not expect any significant changes in its financial results compared to the previous fiscal year. DIH Holdings US, Inc is actively working on compliance efforts, as indicated by the signature of Lynden Bass, the Chief Financial Officer, on the notification.
On August 7, 2025, DIH Holding US, Inc. entered into a Securities Purchase Agreement, resulting in the sale of $2,222,222 in principal amount of 8% Original Issue Discount Senior Secured Convertible Debentures. These debentures, convertible at a price of $0.25, have a maturity date of September 21, 2026, and offer flexibility in redemption and conversion options. The company anticipates gross proceeds of approximately $2.0 million, with net proceeds of $1.9 million intended for working capital and general corporate purposes. This transaction includes a Registration Rights Agreement and a Voting Agreement, ensuring compliance with SEC regulations and shareholder approvals. The issuance of these securities is expected to impact the company’s financial strategy and stakeholder interests.
On August 4, 2025, DIH Holding US, Inc. appointed Scott R. Burell to its Board of Directors, effective until the 2026 Annual Meeting of Stockholders. Burell, a seasoned healthcare finance executive, brings over two decades of experience in leading life sciences companies through complex transactions and growth phases. His appointment is expected to strengthen DIH’s board as the company continues its growth strategy in the rehabilitation robotics market. The board now comprises six members, with four being independent, enhancing the company’s governance structure.
On July 29, 2025, DIH Holding US, Inc. received a notice from Nasdaq indicating non-compliance with listing requirements due to the delayed filing of its Annual Report on Form 10-K for the period ended March 31, 2025. The company has 60 days from the notice date to file the report or submit a compliance plan. This notice does not immediately affect the trading of the company’s securities on Nasdaq, and DIH is actively working to resolve the issue.